Profil
Dr. Richard Philipson, MD, is a Chief Medical Officer at Hansa Biopharma AB and a Member at The Royal College of Physicians.
Dr. Philipson was previously employed as a Chief Medical Officer by Calliditas Therapeutics AB and a Chief Medical Officer by Trizell Ltd. He received his undergraduate degree from the University of London.
Postes actifs de Richard Philipson
| Sociétés | Poste | Début |
|---|---|---|
| HANSA BIOPHARMA AB | Directeur Technique/Scientifique/R&D | 14/07/2025 |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Richard Philipson
| Sociétés | Poste | Fin |
|---|---|---|
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Develops biotechnology products | Directeur Technique/Scientifique/R&D | 01/07/2020 |
| CALLIDITAS THERAPEUTICS AB | Directeur Technique/Scientifique/R&D | - |
Formation de Richard Philipson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calliditas Therapeutics AB
Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
















